Amyloid-beta (A beta) peptide as one of the main components of senile plaques is closely related to the onset and progression of incurable Alzheimer's disease (AD). In recent years, it is reported that curcumin derivatives have been used as the near-infrared (NIR) fluorescence imaging probes of A beta plaques for the early diagnosis of AD. To further develop a curcumin-based NIR fluorescent probe for A beta plaques, in this work, we have synthesized three novel curcumin-based NIR Dyes. Among them, the curcumin derivative Dye 2 showed a significant enhancement in its fluorescence intensity (lambda em, 635 nm; 19.5-fold increase in quantum yield, Phi = 0.36; K-d, 1.13 mu M) after binding to A beta plaques. Additionally, in vitro and in vivo fluorescence imaging of A beta plaques strained with Dye 2 confirmed that the compound was a potential probe to detect A beta plaques in AD. This work opens a perspective to rationally design novel curcumin-based NIR compound for A beta detection.